Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes
Critical Care volume 27, Article number: 439 (2023)
Severe weakness associated with critical illness (CIW) is common. This narrative review summarizes the latest scientific insights and proposes a guide for clinicians to optimize the diagnosis and management of the CIW during the various stages of the disease from the ICU to the community stage.
CIW arises as diffuse, symmetrical weakness after ICU admission, which is an important differentiating factor from other diseases causing non-symmetrical muscle weakness or paralysis. In patients with adequate cognitive function, CIW can be easily diagnosed at the bedside using manual muscle testing, which should be routinely conducted until ICU discharge. In patients with delirium or coma or those with prolonged, severe weakness, specific neurophysiological investigations and, in selected cases, muscle biopsy are recommended. With these exams, CIW can be differentiated into critical illness polyneuropathy or myopathy, which often coexist. On the general ward, CIW is seen in patients with prolonged previous ICU treatment, or in those developing a new sepsis. Respiratory muscle weakness can cause neuromuscular respiratory failure, which needs prompt recognition and rapid treatment to avoid life-threatening situations. Active rehabilitation should be reassessed and tailored to the new patient’s condition to reduce the risk of disease progression. CIW is associated with long-term physical, cognitive and mental impairments, which emphasizes the need for a multidisciplinary model of care. Follow-up clinics for patients surviving critical illness may serve this purpose by providing direct clinical support to patients, managing referrals to other specialists and general practitioners, and serving as a platform for research to describe the natural history of post-intensive care syndrome and to identify new therapeutic interventions. This surveillance should include an assessment of the activities of daily living, mood, and functional mobility. Finally, nutritional status should be longitudinally assessed in all ICU survivors and incorporated into a patient-centered nutritional approach guided by a dietician.
Early ICU mobilization combined with the best evidence-based ICU practices can effectively reduce short-term weakness. Multi-professional collaborations are needed to guarantee a multi-dimensional evaluation and unitary community care programs for survivors of critical illnesses.
In 1984, Bolton described the first 5 cases of “critically ill polyneuropathy” in patients with “adult” respiratory distress syndrome (as these syndromes were called at that time) . Initially, the condition described seemed very rare, as it took 4 years to describe these 5 patients, whose clinical presentation was characterized by profound weakness of “neck, chest wall, abdomen and limb muscles” and absent deep tendon reflexes. In 1987, in a following study of 17 patients, critical illness polyneuropathy (CIP) was associated with “failure to wean” the patient from the ventilator, a diagnosis that was made when “despite partial resolution of the critical illness, the patient could not tolerate a reduction in the frequency of mandatory mechanical ventilation” .
In 1985  and then in 1991 , Op de Coul described 22 patients with combined CIP and critical illness myopathy (CIM) and first proposed the term polyneuromyopathy. In 1995, Leijten found that ICU patients diagnosed with CIP had persisting motor deficits at 1 year, indicating the need for long-term follow-up of ICU survivors . In 1996, we found that CIP may present as an isolated electrophysiological alteration in the early stage of disease (i.e. with maintained nerve structural integrity at nerve biopsy), whereas axonal degeneration occurred typically in patients with persisting symptoms . We described these findings using the concept of bioenergetic failure , where combined CIP and CIM can cause reversible tetraplegia in critically ill comatose patients. During the last 25 years, we learned that combined CIM and CIP is the most common manifestation of acute neuromuscular weakness in the ICU [8, 9].
The term “ICU-acquired weakness” (ICUAW) appeared in 1993 in a report of 5 patients with acute necrotizing myopathy . However, it was not until 2002 that the “ICU-acquired paresis” was systematically investigated in a multicenter French study using the Medical Research Council sum score (MRCss) in patients awakening after prolonged sedation . The investigators found that 25% of patients developed a global, flaccid weakness. A similar incidence of ICUAW of around 25%, was found in 2008 in an American study that used both the MRCss and handgrip dynamometry for assessing muscle strength . Sensitive diagnostic tools have shown that the incidence of ICUAW in patients who slowly recover from the critical illness is 43% (interquartile range 25%-75%)  and is associated with prolonged mechanical ventilation and ICU stay , increased ICU, hospital, 1-year  and 5-year mortality , in-hospital costs , and impaired long-term physical function  and aerobic capacities . With an estimated 13–20 million patients admitted to the ICU worldwide, more than 6 million new patients will experience ICUAW annually : an apparently rare condition has turned into a common and serious ICU complication with long-term consequences.
This article is meant to guide clinicians caring for adult critically ill patients in diagnosing severe muscle weakness associated with critical illness at various stages during the hospital stay and after hospital discharge. We also propose strategies on how to approach muscle weakness during the various stages of the patient’s difficult journey from ICU admission back into the community. In proposing this unitary vision, we emphasize that severe weakness may not be solely “acquired” in the ICU. Instead, it should be seen as the “extreme end of a spectrum of weakness that begins with any serious illness regardless of care location” . Therefore, in this review we will use the term Critical Illness Weakness (CIW), in assonance with CIP and CIM, as a more appropriate and specific description of the generalized weakness that affects acutely ill patients.
In the ICU
CIW presents as a symmetrical muscle weakness arising after the onset of a critical illness, affecting the limbs and the respiratory muscles, and sparing the facial muscles [19, 20]. There is no agreement as to whether diaphragm weakness (DW) should be considered an integral part of the syndrome or a separate entity. Historically, the coexistence of limb weakness and DW was considered the typical presentation of the syndrome . However, DW is poorly correlated with CIW [21,22,23], suggesting that CIW and DW might be distinct entities. The concept of respiratory muscle weakness has further expanded in recent years to involve extra-diaphragmatic inspiratory muscles and expiratory muscles weakness, in addition to DW [24,25,26]. Respiratory muscle weakness is associated with weaning failure, longer duration of mechanical ventilation, and, if present at ICU discharge, increased risk of in-hospital mortality, ICU and hospital readmission  and worse physical function and quality of life at long-term evaluation .
CIW is a diagnosis of exclusion when generalized and symmetrical limb weakness after ICU admission develops in the absence of other etiology . These features are important to distinguish CIW from Guillain-Barré syndrome, myasthenia gravis, acute myopathies and neuropathies, amyotrophic lateral sclerosis, drug overdose, envenomation and other conditions that may cause acute neuromuscular respiratory failure [28, 29]. Differential diagnosis is usually obvious, as these conditions are typically a cause of ICU admission, and not a complication of critical illness during ICU stay . Conversely, CIW is commonly diagnosed in patients with persisting critical illness  who have normal muscle strength at ICU admission: among patients still in the ICU on day 8 after admission, the incidence of CIW is higher than 50% . Some neuromuscular diseases may have an acute onset, and some chronic conditions may have sudden exacerbations, thereby presenting with acute respiratory failure . These cases represent a diagnostic challenge, because limb weakness becomes apparent when the acute phase of respiratory failure has resolved and patients are weaned off sedatives, thus posing the problem of whether the weakness is pre-existing upon admission to the ICU or developed during the ICU stay. If the etiological diagnosis is not clear at ICU admission, differential diagnosis requires meticulous attention to neurological signs  (i.e. weakness of eye muscles with ptosis and ocular palsy in myasthenia gravis; asymmetrical distribution of muscle weakness such as hemiparesis in acute ischemic stroke; poorly reactive dilated pupils as in botulin intoxication; autonomic signs, such as cardiac arrhythmias or blood pressure fluctuations as in Guillain-Barré syndrome) and specialized neurophysiological investigations [29, 32].
In cooperative patients, muscle strength should be assessed at the bedside using the MRC scale, handgrip dynamometry (HGD), or both . MRC sum score (MRCss) should be assessed as soon as the patient awakens and at ICU discharge at the very minimum, while handgrip dynamometry can be used as a quick screening tool throughout the ICU stay (Fig. 1) . Critical care nurses may also identify signs and symptoms of severe weakness using a subjective assessment tool, and their findings should also be considered during interprofessional rounds .
The term CIW condenses various neurophysiological and neuropathological entities with different prognoses into one single clinical entity. Therefore, if weakness persists, electrophysiological investigations of peripheral nerves and muscles and, in selected cases, muscle biopsy (Fig. 2) will eventually be required to define the specific pathological diagnosis and tailor the treatment plan . In the era of “precision critical care medicine” , a more specific diagnosis may inform long-term prognosis (Table 1)  and may hopefully enable targeted pharmacological treatments in the near future, as it is for other neuromuscular disorders with axonal nerve transport dysfunction  or muscle electrical excitability alterations.
In patients with impaired brain function who are unable to engage with voluntary muscle strength measurements, instrumental diagnosis may help to establish a diagnosis of CIP or CIM. The simplified electrophysiological peroneal nerve test (PENT) can quickly detect a reduction of the compound muscle action potential amplitude  and may indicate the need for further neurophysiological investigations (Fig. 2) ). In patients with septic shock requiring moderate or deep sedation, the use of PENT allows early diagnosis of CIP and CIM, before muscle weakness becomes clinically evident . Isolated electrophysiological alterations of peripheral nerves and muscles (i.e. without discernible muscle weakness) at ICU discharge can differentiate pre-hospital discharge functional status  and are independently associated with increased 5-year mortality . Neuromuscular ultrasound (NMUS) shows promise as an easily repeatable, noninvasive technique for detecting CIP and CIM. In CIP, NMUS may describe changes in thickness, cross-sectional area and echogenicity in nerves of the upper and lower extremities . Increased nerve cross-sectional area, suggesting nerve enlargement, may distinguish between CIP and CIM and correlates with the duration of mechanical ventilation and days spent in the ICU . In CIM, NMUS may identify changes in limb muscle mass and architecture by measuring the muscle layer thickness, cross-sectional area and echointensity, which correlate with functional outcomes and mortality [42,43,44]. NMUS can identify necrosis of muscle fibers , which has a worse prognosis than loss of thick myosin filaments , and fascial inflammation and fasciitis, which may cause severe pain [19, 45]. Ultrasound can be used to assess the diaphragm thickening fraction which predicts ventilator weaning failure , to titrate ventilatory support, and to evaluate patient-ventilator interaction, diaphragmatic paralysis and progression of atrophy in mechanically ventilated patients [19, 46]. Other more contemporary techniques include force measurements by combining electrical or magnetic supramaximal stimulation applied either over a motor nerve or a muscle belly with an ergometer. Some ergometers allow the measurement of evoked muscle force in response to stimulation on three muscle groups: adductor pollicis, ankle dorsiflexors, and quadriceps. These techniques have been recently reviewed in detail .
CIW and delirium are common ICU complications and often coexist [19, 48]; indeed, “neck down” neuromuscular disorders are often associated with “neck up” brain disorders  (see Fig. 2 in ). CIW cannot be reliably assessed if the patient is delirious; even hyperactive delirium can be difficult to assess if the patient is severely weak. Since the facial muscles are unaffected in CIW, the only sign of agitation can be a ceaseless crescendo and diminuendo of lateral head movements. In patients with CIW who also have delirium, sternal or nail bed pressure will lead to facial grimacing despite reduced or absent limb movement .
In comatose patients, the absence of reflex motor response of the limbs to pain caused by CIP and CIM can be reversible . This can be seen in non-neurological ICU septic patients with encephalopathy  or diabetic patients with hyperosmolar coma , but also in neurologic patients developing sepsis . In these cases, brainstem reflexes, such as pupillary light and corneal reflexes, remain intact [6, 53]. By contrast, the same clinical picture portends a grim prognosis if it is caused by an acute brain disease and is associated with altered brainstem reflexes . Thus, a careful neurologic examination is vital to differentiate whether the absent motor responsiveness is due to peripheral or central causes. Since predicted outcomes can affect patient’s treatment , an accurate differential diagnosis is also important to avoid a decision to withdraw life-sustaining therapy in patients with reversible paralysis .
In patients emerging from coma, the presence of facial muscle movements in response to pain (i.e. grimacing) combined with normal brainstem reflexes, nystagmus and slowly roving, spontaneous, conjugate eye movements suggests a peripheral mechanism of severe muscle weakness (Fig. 3) .
In patients with cognitive-motor dissociation (covert consciousness) [56, 57], who recover their cognitive function with a substantially delayed recovery of muscle function, electrophysiological neuromuscular investigations are paramount to consolidate or exclude the diagnosis of CIP and CIM as the cause of motor impairment .
What should be done once CIW is documented in the ICU? Physical rehabilitation is important and should be started soon after CIW is diagnosed. Functional exercises, such as sitting, standing, and walking, are the most effective rehabilitation goals in the ICU  and should be reevaluated continuously as the patient’s condition changes . Since bed resting is an important risk factor for CIW , preventive strategies such as early mobilization, started when the patient condition is physiologically stable (usually within 2–3 days of ICU admission and hence, before the development of CIW), is recommended by clinical practice guidelines . Early mobilization can mitigate the physical dysfunction at hospital discharge, provided that patient safety is guaranteed and the level and duration of activity are tuned to individual needs [59, 63, 64]. Device-assisted physical therapy is increasingly used to facilitate early mobilization even though guidelines do not yet recommend its use . The ABCDEF bundle (Assess, prevent, and manage pain; Both spontaneous awakening and breathing trials: Choice of Analgesia and Sedation; Delirium assess, prevent, and manage; Early Mobility and Exercise; Family engagement/empowerment), one of whose elements is early mobilization, enables a holistic integrated approach to the patient . Unwanted deep sedation prevents patient interaction with the ICU team and the family, is a risk factor for delirium and causes immobility, contributing to long-lasting physical and cognitive impairments. A protocol of light or no-sedation is acceptable to most patients , is perfectly suited for early mobilization and occupational therapy, may reduce delirium duration and improve long-term weakness and cognitive outcomes .
In the hospital ward
Ideally, no patient should be discharged from the ICU without having the muscle strength assessed and the MRCss recorded, as even a mild MRCss reduction ≤ 55 is associated with increased long-term morbidity and mortality up to 5 years [15, 69]. Diagnosis of CIW should be reported in the clinical chart and the need for discharge to a rehabilitation center should be anticipated. However, CIW remains an underrecognized disease [70, 71], and many patients are transferred to the general ward without proper assessment of muscle strength. This may expose the patient to serious complications on the floor, such as acute neuromuscular respiratory failure, a life-threatening condition with a difficult diagnosis and insidious progression. Weak cough with an inability to clear secretions, cough after swallowing (indicating dysphagia), staccato speech (i.e. the need to pause between words while speaking), rapid shallow breathing, and breathlessness when swallowing are important warning signs indicating imminent respiratory failure [29, 72, 73]. Arterial blood gases worsen only late in the course of the disease and chest X-ray is often normal or shows only reduced chest expansion [29, 72]. If CIW is diagnosed, patients should receive immediate attention; sepsis and respiratory muscle weakness should be actively sought, and, if present, should dictate close patient monitoring, or even ICU readmission if this is in the best interest of the patient. Dysphagia, an additional neuromuscular dysfunction  which is common after tracheal intubation and mechanical ventilation , is worth being evaluated because early bedside assessment  can reduce serious complications such as choking, aspiration pneumonia, and respiratory failure .
Severe weakness may not be solely “acquired” in the ICU. In patients with sepsis, which is a major problem in hospital wards where in fact 50% of patients with sepsis are treated [78, 79], CIW develops in up to 64% of patients . The incidence of CIW may be similar in patients with sepsis admitted to internal medicine wards, where in fact the "Sepsis-3" diagnostic criteria work just as well as in the ICU and the sequential organ failure assessment (SOFA) score is closely associated with in-hospital mortality . This suggests that the process leading to the failure of body organ systems, including that of the neuromuscular system, is the same regardless of the environment in which sepsis develops. Sir William Osler describing sepsis in 1892, well before the intensive care medicine was born, observed: “The constitutional disturbance is marked and there are loss of appetite, nausea and vomiting, and, as the disease progresses, rapid loss of flesh” . To date, CIW outside the ICU is described only anecdotally  or in small series , and this is an important area for future clinical investigations. Acute kidney injury (AKI) and days on renal replacement therapy are risk factors for CIW . AKI alters the tissue use of amino acids even in its early stage, thereby making it plausible that AKI exacerbates CIM . Interestingly, CIP has long been described outside the ICU in patients developing sepsis in the course of severe kidney failure . Patients with abdominal infections, pancreatitis and trauma admitted to surgical wards are also prone to develop CIW . Therefore, CIW can be a common encounter for general ward physicians and nurses or critical care outreach teams. Assessing muscle strength should become a common practice in these patients, as is measuring the blood pressure or assessing pain, and the term CIW can help break down the myth that severe weakness is observed only in ICU patients. Provision of longitudinal follow-up can facilitate maintaining active rehabilitation initiated in the ICU without unwanted interruptions . In the UK, a Post-ICU Presentation Screen (PICUPS) has been developed as a screening tool to identify rehabilitation needs in patients stepping down from ICU and the general ward into rehabilitation and the community .
As suggested by convenors in a round table meeting that was held in Brussels in March 2016, we should “embrace the continuum of illness including pre-ICU trajectory, recovery, and adaptation” to optimize outcomes . Post-ICU discharge is an integral part of this continuum, and, as such, it needs careful planning and a coordinated approach by multidisciplinary teams tailoring management to the actual patient’s needs . With “byzantine” post ICU-transitions , less than 1 in 10 patients recover to functional independence.
After hospital discharge
When sorrows come, they come not single spies, but in battalions (Shakespeare, Hamlet, Act IV, Scene V).
Survivorship is a crucial challenge facing modern critical care medicine, as Iwashyna predicted more than 10 years ago . Determinants of long-term physical impairment are myriad  and include pre-existing conditions as well as ICU and post-ICU factors. Importantly, ICU patients develop new pathological processes that are “both organic and iatrogenic” . Meticulous attention should be paid to reducing iatrogenic events, such as deep sedation or immobility, and there must be a continuum of care for patients—and families too—extending from the ICU to community or primary care to provide optimal outcomes for critically ill patients . In the UK, follow-up programs after ICU admission are embedded in national rehabilitation guidelines . Physical disability after acute care hospital discharge does not come in isolation; instead, it is often associated with cognitive and mental impairments , which all together impact the quality of life and return to work (Case Vignette). Therefore, the approach to ICU survivors should consider a multidisciplinary model of care, as recently emphasized also in COVID-19 survivors . This is reinforced by the fact that, with improving experience, other conditions have been described to be part of post-intensive care syndrome (PICS), such as new-onset diabetes (particularly in patients with stress hyperglycemia during the ICU stay ), endocrine disturbances, sleep disorders, dysphagia, sexual dysfunctions [92, 93], pain and autonomic dysfunction [19, 94]. Follow-up clinics for patients surviving critical illness may serve this purpose by providing direct clinical support to patients, managing referrals to other specialists and general practitioners, and serving as a platform for research on the natural history of PICS and the assessment of new therapeutic interventions (Fig. 4) [90, 95]. Follow-up clinics may become an important referral for family physicians, since ICU survivors consult them more frequently than non-ICU patients with similar morbidities ; therefore, it is essential that family physicians are aware of the close link between acute ICU events and long-term disability (Case Vignette).
A previously healthy 57-year-old woman was referred by her family physician to the follow-up center 11 months after her ICU admission for pneumonia and septic shock. In the ICU, she was sedated with propofol, received neuromuscular blocking agents for mechanical ventilation and was treated with antibiotics, vasopressors, steroids, and opioids for pain control and suffered hypo-active delirium for 4 days. After 11 days, the patient was extubated and two days later was transferred to the division of pulmonary medicine. Although she was unable to lift her arms and legs against gravity, a formal evaluation of muscle strength was not done. She was discharged home on day 26. Two months later, she resumed her job as a bank accountant but quit after a few weeks because she felt fatigued, and her mind was foggy. She also reported difficulty walking and climbing stairs. During the 11 months after discharge, she was seen several times by her family physician and by specialists including a pulmonologist, a neurologist, a cardiologist, a psychologist, and an expert in non-conventional medicine. A treatment with anti-depressants was temporarily beneficial.
The family physician, after attending a conference on post-intensive care syndrome, prescribed a visit to our follow-up clinic, where the patient demonstrated signs of a sensorimotor neuropathy with reduced muscle strength especially in the lower limbs and gait disturbances. Electromyographic findings were consistent with a sensory-motor axonal polyneuropathy. The 6-minute walk test and handgrip dynamometry were 70% and 78% of percentage predicted, respectively. The Montreal Cognitive Assessment (MOCA) was 25, indicating mild cognitive impairment. The mini-nutritional test score was 10 indicating risk for malnutrition. The Hospital Anxiety and Depression Scale (HADS) for depression showed borderline depression (score: 9), whereas HADS for anxiety showed severe anxiety (score: 13). There was no evidence of post-traumatic stress disorder. The Fatigue Severity Score was 23, indicating severe fatigue. The physical and mental component summary scores of the SF36 were also altered (scores: 42 and 44, respectively).
The patient was informed that all her symptoms were part of the post-intensive care syndrome and that she could improve with time. She was prescribed a physical therapy program with a physiotherapist every weekday, consisting of walking at least 30 minutes at a brisk pace twice a day every day, and a diet with 35Kcal/Kg and amino acids supplement (5 to 10 mg daily). She was also referred to a clinical psychologist.
The patient was very pleased with such a comprehensive examination and was very relieved that the condition was potentially reversible, because she was convinced that she had a progressive degenerative disease or cancer.
At two years, when last seen, the patient’s condition had greatly improved in all PICS domains. She had returned to work, albeit with reduced hours, and enjoyed renewed activity in social life.
Severe muscle weakness may persist for months to years after hospital discharge, and many patients may not recover to their pre-ICU condition. In the ICAP study in survivors of acute lung injury, CIW was diagnosed in 36% of patients at hospital discharge and was still persisting in 14% at 1 year and 9% at 2 years . In the ALTOS study in ARDS survivors, 6% of patients had persisting CIW at 1 year . Physical sequelae are also common in sepsis survivors; indeed, hundreds of thousands of sepsis survivors, not only patients treated in the ICUs , face the challenge of persisting physical disability . Sepsis survivors often report a significant deterioration of their perceived physical function compared with pre-admission status . When physical function is measured using objective methods in older patients, sepsis negatively impacts activities of daily living (ADL) and instrumental ADL (IADL), particularly in patients with better baseline physical functioning . In surgical patients with chronic critical illness (≥ 14 ICU days), sepsis has a devasting effect on physical function: patients are not only limited in their ADL, but they can also be confined to bed or a chair most of the day for months after ICU discharge . Physical impairments, including reduced 6 min walk distance (6MWD), 4 m gait speed, hand grip, MRCss and pulmonary function, are equally common in patients with hyper-inflammatory and hypo-inflammatory sepsis-associated ARDS subphenotypes , suggesting that inflammation may not be a key driving mechanism of long-term functional impairments in this population.
Recovery of physical functioning requires not only the recovery of muscle strength. Accordingly, the physical assessment in ICU survivors should consider a comprehensive approach that evaluates factors at the level of the body function and structure, and the whole person in a standardized environment and in a societal context (Table 2) [105,106,107]. As an example, reduced 6MWD indicates a whole person’s physical dysfunction, since the test evaluates the integrated responses of the neuromuscular units, muscle metabolism, pulmonary and cardiovascular systems, and blood, but also the joints (range of motion), the brain (proprioception, balance, cognition), and the mind (motivation) .
Chronic muscle denervation consistent with previous CIP can be found up to 5 years after ICU discharge in > 90% of long-ICU stay patients (> 28 days) . CIP persists longer than CIM and causes prolonged muscle weakness and paralysis . Even in milder cases with complete functional recovery, CIP can cause reduced or absent deep tendon reflexes, stocking and glove sensory loss, and painful hyperesthesia . The PENT can be usefully implemented to define the cause(s) of symptoms, as it is easily acquired, is quick (10 min ) and can be used to screen patients needing more in-depth electrophysiological investigations, replicating the scheme used during the ICU stay (Fig. 2).
In the general adult population in the USA, peripheral neuropathy with decreased lower-extremity sensation commonly affects adults with diabetes but is also described in subjects with normoglycemia and is independently associated with mortality . CIP is itself a peripheral neuropathy involving the sensory nerves, not only the motor nerves, and is associated with stocking and glove sensory loss and painful hyperesthesia in ICU survivors . As such, CIP might contribute to the problem of decreased sensation in the lower limb and increased mortality described in the general adult population. This further emphasizes the need for actively seeking CIP not only in ICU survivors with persistent weakness, but also in those with persisting altered sensation in lower extremities. If CIP is diagnosed, referral to a rehabilitation physician and physiotherapist is warranted , particularly for patients with high comorbid burden .
Optimal nutrition also needs to be addressed. Nutritional status is seldom considered in the context of ICU recovery, even though critical illness is associated with malnutrition . Body weight loss, a cardinal sign of malnutrition, is common in ICU patients who lose nearly 2% of lean body mass per day during the first week of their ICU stay . At 1 year, only one-third of patients have regained their body weight  and, among those who gain weight, there can be an increase in fat mass rather than lean body mass . Reasons for persisting malnutrition include physiological, functional, psychological and organizational barriers and have been reviewed elsewhere . The nutritional status can be examined using simple tools, such as the mini-nutritional assessment short-form . Factors that can limit adequate energy and protein intake should be actively investigated, particularly loss of appetite that can persist for months after ICU discharge . Loss of appetite and reduced oral intake can be more pronounced when reported by the patient than when objectively assessed with a standard buffet meal  and can be associated with severe depression , again indicating the need for a multidisciplinary approach in these patients. No specific guidelines on macro- and micronutrient requirements are available for ICU survivors, but experts suggest that nutritional requirements are higher than in healthy patients  and may remain so for long . Oral nutrition supplements with high-protein and β-hydroxy β-methyl butyrate may be useful after post-hospital discharge. Propranolol, oxandrolone, and other anabolic/anti-catabolic agents may also help to restore lean muscle mass  and might be incorporated into a patient-centered nutritional approach with regular dietician follow-up visits.
Conclusions and future directions
Severe weakness is a common complication of critical illness impacting short and long-term outcomes and should be actively sought in all hospitalized patients with serious illnesses. No effective pharmacological treatments are available, but early ICU mobilization adapted to the specific patient’s needs together with the best evidence-based ICU practices, such as the ABCDEF bundle, can effectively improve muscle strength.
Weak patients seen at follow-up need appropriate multi-dimensional evaluation and close multi-professional collaborations. Follow-up clinics may serve as a hub to connect and coordinate different medical specialists, physiotherapists, dieticians, psychologists, and family physicians into a unitary physical, cognitive, and psychosocial community care program for survivors of critical illnesses.
Future studies should assess whether a comprehensive approach with pharmacological treatments, and rehabilitation and nutritional strategies begun during hospitalization and maintained for a sufficiently long time after hospital discharge combined with adequately planned post-ICU and post-hospital care transitions can effectively reduce CIW.
Availability of data and materials
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47:1223–31.
Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. Brain. 1987;110:819–41.
Op de Coul AA, Lambregts PC, Koeman J, van Puyenbroek MJ, Ter Laak HJ, Gabreëls-Festen AA. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg. 1985;87:17–22.
Op de Coul AA, Verheul GA, Leyten AC, Schellens RL, Teepen JL. Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg. 1991;93:27–33.
Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;274:1221–5.
Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, et al. Critical illness myopathy and neuropathy. Lancet. 1996;347:1579–82.
Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care. 2007;11:R11.
Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10:931–41.
Latronico N, Hermans G. Critical illness neuromyopathy: clinical, electrophysiological, and histological diagnosis. In: Preiser J-C, Herridge M, Azoulay E, editors. Post-intensive care syndrome. Cham: Springer International Publishing; 2020. p. 43–59.
Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol. 1993;52:387–98.
De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859–67.
Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JCW, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178:261–8.
Fan E, Cheek F, Chlan L, Gosselink R, Hart N, Herridge MS, et al. An official American thoracic society clinical practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190:1437–46.
Hermans G, Van Mechelen H, Bruyninckx F, Vanhullebusch T, Clerckx B, Meersseman P, et al. Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU. Intensive Care Med. 2015. https://doi.org/10.1007/s00134-015-3979-7.
Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, et al. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020;46:1184–93.
Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190:410–20.
Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Casaer MP, Gunst J, et al. Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study. Intensive Care Med. 2021;47:1462–71.
Wang W, Xu C, Ma X, Zhang X, Xie P. Intensive care unit-acquired weakness: a review of recent progress with a look toward the future. Front Med. 2020;7: 559789.
Latronico N, Herridge M, Hopkins RO, Angus D, Hart N, Hermans G, et al. The ICM research agenda on intensive care unit-acquired weakness. Intensive Care Med. 2017;43:1270–81.
Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299-308.
Dres M, Dubé B-P, Mayaux J, Delemazure J, Reuter D, Brochard L, et al. Coexistence and impact of limb muscle and diaphragm weakness at time of liberation from mechanical ventilation in medical intensive care unit patients. Am J Respir Crit Care Med. 2017;195:57–66.
Saccheri C, Morawiec E, Delemazure J, Mayaux J, Dubé B-P, Similowski T, et al. ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients. Ann Intensive Care. 2020;10:1.
Bertoni M, Piva S, Beretta A, Bongiovanni F, Contarino R, Artigas RM, et al. Occurrence and effects on weaning from mechanical ventilation of intensive care unit acquired and diaphragm weakness: a pilot study. Front Med. 2022;9: 930262.
Shi Z-H, Jonkman A, de Vries H, Jansen D, Ottenheijm C, Girbes A, et al. Expiratory muscle dysfunction in critically ill patients: towards improved understanding. Intensive Care Med. 2019;45:1061–71.
Pozzi M, Rezoagli E, Bronco A, Rabboni F, Grasselli G, Foti G, et al. Accessory and expiratory muscles activation during spontaneous breathing trial: a physiological study by surface electromyography. Front Med. 2022;9: 814219.
Bureau C, Van Hollebeke M, Dres M. Managing respiratory muscle weakness during weaning from invasive ventilation. Eur Respir Rev. 2023. https://doi.org/10.1183/16000617.0205-2022.
Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, et al. Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort study. Thorax. 2021;76:561–7.
Cabrera Serrano M, Rabinstein AA. Causes and outcomes of acute neuromuscular respiratory failure. Arch Neurol. 2010;67:1089–94.
Latronico N, Fagoni N. Neuromuscular disorders and acquired neuromuscular weakness. In: Smith MM, Citerio G, Kofke AWI, editors. Oxford Textbook of Neurocritical Care. Oxford University Press; 2016. p. 282–300.
Iwashyna TJ, Hodgson CL, Pilcher D, Bailey M, van Lint A, Chavan S, et al. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respir Med. 2016;4:566–73.
Sharshar T, Citerio G, Andrews PJD, Chieregato A, Latronico N, Menon DK, et al. Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel. Intensive Care Med. 2014;40:484–95.
Piva S, Bertoni M, Gitti N, Rasulo FA, Latronico N. Neurological complications of sepsis. Curr Opin Crit Care. 2023;29:75–84.
Parry SM, Berney S, Granger CL, Dunlop DL, Murphy L, El-Ansary D, et al. A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study. Crit Care. 2015;19:52.
Friedrich S, Teja B, Latronico N, Berger J, Muse S, Waak K, et al. Subjective assessment of motor function by the bedside nurses in mechanically ventilated surgical intensive care unit patients predicts tracheostomy. J Intensive Care Med. 2023;38:151–9.
Latronico N, Gosselink R. A guided approach to diagnose severe muscle weakness in the intensive care unit. Rev Bras Ter Intensiva. 2015;27:199–201.
Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28:1141–8.
Yang C, Zhao X, An X, Zhang Y, Sun W, Zhang Y, et al. Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy. Front Endocrinol. 2023;14:1136796.
Latronico N, Nattino G, Guarneri B, Fagoni N, Amantini A, Bertolini G, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. 2014;3:127.
Attwell C, Sauterel L, Jöhr J, Piquilloud L, Kuntzer T, Diserens K. Early detection of ICU-acquired weakness in septic shock patients ventilated longer than 72 h. BMC Pulm Med. 2022;22(1):466. https://doi.org/10.1186/s12890-022-02193-7.
Kelmenson DA, Quan D, Nordon-Craft A, Malone D, Schenkman M, Moss M. Electrophysiological abnormalities can differentiate pre-hospital discharge functional status in critically ill patients with normal strength. Intensive Care Med. 2016;42:1504–5.
Klawitter F, Walter U, Axer H, Patejdl R, Ehler J. Neuromuscular ultrasound in intensive care unit-acquired weakness: current state and future directions. Medicina. 2023. https://doi.org/10.3390/medicina59050844.
Parry SM, El-Ansary D, Cartwright MS, Sarwal A, Berney S, Koopman R, et al. Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function. J Crit Care. 2015;30(1151):e9-14.
Mayer KP, Thompson Bastin ML, Montgomery-Yates AA, Pastva AM, Dupont-Versteegden EE, Parry SM, et al. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020;24:637.
Casey P, Alasmar M, McLaughlin J, Ang Y, McPhee J, Heire P, et al. The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review. J Cachexia Sarcopenia Muscle. 2022;13:2298–309.
Puthucheary ZA, Phadke R, Rawal J, McPhail MJW, Sidhu PS, Rowlerson A, et al. Qualitative ultrasound in acute Critical Illness muscle wasting. Crit Care Med. 2015;43:1603–11.
Tuinman PR, Jonkman AH, Dres M, Shi ZH, Goligher EC, Goffi A, et al. Respiratory muscle ultrasonography: methodology, basic and advanced principles and clinical applications in ICU and ED patients-a narrative review. Intensive Care Med. 2020;46:594–605.
Kennouche D, Luneau E, Lapole T, Morel J, Millet GY, Gondin J. Bedside voluntary and evoked forces evaluation in intensive care unit patients: a narrative review. Crit Care. 2021;25:157.
Ballve LPD, Dargains N, Inchaustegui JGU, Bratos A, de Percaz MLM, Ardariz CB, et al. Weakness acquired in the intensive care unit. Incidence, risk factors and their association with inspiratory weakness. Observational cohort study. Rev Bras Ter Intensiva. 2017. https://doi.org/10.5935/0103-507x.20170063.
Mart MF, Pun BT, Pandharipande P, Jackson JC, Ely EW. ICU survivorship—the relationship of delirium, sedation, dementia, and acquired weakness. Crit Care Med. 2021;Publish Ahead of Print:1227–40.
Luitse MJA, van Asch CJJ, Klijn CJM. Deep coma and diffuse white matter abnormalities caused by sepsis-associated encephalopathy. Lancet. 2013;381:2222.
Kennedy DD, Fletcher SN, Ghosh IR, Coakley JH, Monson JP, Hinds CJ. Reversible tetraplegia due to polyneuropathy in a diabetic patient with hyperosmolar non-ketotic coma. Intensive Care Med. 1999;25:1437–9.
Latronico N, Rasulo FA, Recupero D, Beindorf A, Liberini P, Stefini R, et al. Acute quadriplegia with delayed onset and rapid recovery. Case Rep J Neurosurg. 1998;88:769–72.
Edlow JA, Rabinstein A, Traub SJ, Wijdicks EFM. Diagnosis of reversible causes of coma. Lancet. 2014;384:2064–76.
Murray LS, Teasdale GM, Murray GD, Jennett B, Miller JD, Pickard JD, et al. Does prediction of outcome alter patient management? Lancet. 1993;341:1487–91.
Edlow BL, Fins JJ. Assessment of covert consciousness in the intensive care unit: clinical and ethical considerations. J Head Trauma Rehabil. 2018;33:424–34.
Edlow BL, Claassen J, Schiff ND, Greer DM. Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies. Nat Rev Neurol. 2021;17:135–56.
Edlow BL, Fecchio M, Bodien YG, Comanducci A, Rosanova M, Casarotto S, et al. Measuring consciousness in the intensive care unit. Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01706-4.
Latronico N. Peripheral causes of cognitive motor dissociation in patients with vegetative or minimally conscious state. JAMA Neurol. 2016.
Hodgson CL, Kho ME, da Silva VM. To mobilise or not to mobilise: is that the right question? Intensive Care Med. 2023;49:1000–4.
NICE. Rehabilitation after critical illness in adults. Quality standard. QS 158. London, UK: National Institute for Health and Care Excellence, 2017. Available from: https://www.nice.org.uk/guidance/qs158/chapter/About-this-quality-standard
Asher RAJ. Dangers of going to bed. BMJ. 1947;2:967–8.
Lang JK, Paykel MS, Haines KJ, Hodgson CL. Clinical practice guidelines for early mobilization in the ICU: a systematic review. Crit Care Med. 2020;48:e1121–8.
Scheffenbichler FT, Teja B, Wongtangman K, Mazwi N, Waak K, Schaller SJ, et al. Effects of the level and duration of mobilization therapy in the surgical ICU on the loss of the ability to live independently: an international prospective cohort study. Crit Care Med. 2021;49:e247–57.
TEAM Study Investigators and the ANZICS Clinical Trials Group, Hodgson CL, Bailey M, Bellomo R, Brickell K, Broadley T, et al. Early active mobilization during mechanical ventilation in the ICU. N Engl J Med. 2022;387:1747–58.
Renner C, Jeitziner M-M, Albert M, Brinkmann S, Diserens K, Dzialowski I, et al. Guideline on multimodal rehabilitation for patients with post-intensive care syndrome. Crit Care. 2023;27:301.
Pun BT, Balas MC, Barnes-Daly MA, Thompson JL, Aldrich JM, Barr J, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU liberation collaborative in over 15,000 adults. Crit Care Med. 2019;47:3–14.
Eikermann M, Needham DM, Devlin JW. Multimodal, patient-centred symptom control: a strategy to replace sedation in the ICU. Lancet Respir Med. 2023. https://doi.org/10.1016/S2213-2600(23)00141-8.
Patel BK, Wolfe KS, Patel SB, Dugan KC, Esbrook CL, Pawlik AJ, et al. Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial. Lancet Respir Med. 2023. https://doi.org/10.1016/S2213-2600(22)00489-1.
Dinglas VD, Aronson Friedman L, Colantuoni E, Mendez-Tellez PA, Shanholtz CB, Ciesla ND, et al. Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors. Crit Care Med. 2017;45:446–53.
Hough CL, Lieu BK, Caldwell ES. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care. 2011;15:R43.
Connolly BA, Jones GD, Curtis AA, Murphy PB, Douiri A, Hopkinson NS, et al. Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care. 2013;17:R229.
Latronico N, Guarneri B, Alongi S, Bussi G, Candiani A. Acute neuromuscular respiratory failure after ICU discharge. Report of five patients. Intensive Care Med. 1999;25:1302–6.
Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care. 2005;11:381–90.
Schefold JC, Wollersheim T, Grunow JJ, Luedi MM, Z’Graggen WJ, Weber-Carstens S. Muscular weakness and muscle wasting in the critically ill. J Cachexia Sarcopenia Muscle. 2020;11:1399–412.
Schefold JC, Berger D, Zürcher P, Lensch M, Perren A, Jakob SM, et al. Dysphagia in mechanically ventilated ICU patients (DYnAMICS): a prospective observational trial. Crit Care Med. 2017;45:2061–9.
Perren A, Zürcher P, Schefold JC. Clinical approaches to assess post-extubation dysphagia (PED) in the critically ill. Dysphagia. 2019;34:475–86.
Zuercher P, Moret CS, Dziewas R, Schefold JC. Dysphagia in the intensive care unit: epidemiology, mechanisms, and clinical management. Crit Care. 2019;23:103.
Bhattacharjee P, Edelson DP, Churpek MM. Identifying patients with sepsis on the hospital wards. Chest. 2017;151:898–907.
Fortini A, Faraone A, Meini S, Bettucchi M, Longo B, Valoriani B, et al. Validity of “Sepsis-3” criteria in identifying patients with community-onset sepsis in Internal Medicine wards; a prospective, multicenter study. Eur J Intern Med. 2021;85:92–7.
Osler W. The principles and practice of medicine, designed for the use of practitioners and students of medicine. New York: D. Appleton and Company; 1892.
Latronico N, Rasulo FA. Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care. 2010;16:123–7.
Teixeira JP, Mayer KP, Griffin BR, George N, Jenkins N, Pal CA, et al. Intensive care unit-acquired weakness in patients with acute kidney injury: a contemporary review. Am J Kidney Dis. 2023;81:336–51.
Teixeira JP, Griffin BR, Pal CA, González-Seguel F, Jenkins N, Jones BM, et al. Critical illness myopathy and trajectory of recovery in acute kidney injury requiring continuous renal replacement therapy: a prospective observational trial protocol. BMJ Open. 2023;13: e072448.
Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol. 1993;33:94–100.
Connolly B, Milton-Cole R, Adams C, Battle C, McPeake J, Quasim T, et al. Recovery, rehabilitation and follow-up services following critical illness: an updated UK national cross-sectional survey and progress report. BMJ Open. 2021;11: e052214.
Turner-Stokes L, Corner EJ, Siegert RJ, Brown C, Wallace S, Highfield J, et al. The post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part I: development and preliminary clinimetric evaluation. J Intensive Care Soc. 2022;23:253–63.
Herridge MS, Azoulay É. Outcomes after critical illness. N Engl J Med. 2023;388:913–24.
Iwashyna TJ. Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med. 2010;153:204–5.
Latronico N, Herridge MS. Unraveling the myriad contributors to persistent diminished exercise capacity after critical illness. Intensive Care Med. 2015. 1854–6.
Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9:1328–41.
Ali Abdelhamid Y, Kar P, Finnis ME, Phillips LK, Plummer MP, Shaw JE, et al. Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: a systematic review and meta-analysis. Crit Care. 2016. https://doi.org/10.1186/s13054-016-1471-6.
Ulvik A, Kvåle R, Wentzel-Larsen T, Flaatten H. Sexual function in ICU survivors more than 3 years after major trauma. Intensive Care Med. 2008;34:447–53.
Rousseau A-F, Prescott HC, Brett SJ, Weiss B, Azoulay E, Creteur J, et al. Long-term outcomes after critical illness: recent insights. Crit Care. 2021;25:108.
Latronico N, Filosto M, Fagoni N, Gheza L, Guarneri B, Todeschini A, et al. Small nerve fiber pathology in critical illness. PLoS ONE. 2013;8: e75696.
Latronico N, Piva S, Rasulo F. Following up the patients at long term. In: Bellani G, editor. Mechanical ventilation from pathophysiology to clinical evidence. Cham: Springer International Publishing; 2022. p. 279–87.
van Sleeuwen D, de Man S, Zegers M, Akkermans R, Ricking M, Peters M, et al. Post-intensive care syndrome in primary care: the development of new diseases and primary care services utilisation—a prospective cohort study. Eur J Gen Pract. 2023;29:2213476.
Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014;42:849–59.
Needham DM, Wozniak AW, Hough CL, Morris PE, Dinglas VD, Jackson JC, et al. Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am J Respir Crit Care Med. 2014;189:1214–24.
Prescott HC, Iwashyna TJ, Blackwood B, Calandra T, Chlan LL, Choong K, et al. Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med. 2019;200:972–81.
Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60:1070–7.
Poulsen JB, Møller K, Kehlet H, Perner A. Long-term physical outcome in patients with septic shock. Acta Anaesthesiol Scand. 2009;53:724–30.
Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787–94.
Gardner AK, Ghita GL, Wang Z, Ozrazgat-Baslanti T, Raymond SL, Mankowski RT, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs. Crit Care Med. 2019;47:566–73.
Hashem MD, Hopkins RO, Colantuoni E, Dinglas VD, Sinha P, Aronson Friedman L, et al. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial. Thorax. 2022;77:22–30.
World Health Organization (WHO). How to use the ICF: A practical manual for using the International Classification of Functioning, Disability and Health (ICF). https://www.who.int/classifications/drafticfpracticalmanual.pdf. Geneva; 2013.
Parry SM, Huang M, Needham DM. Evaluating physical functioning in critical care: considerations for clinical practice and research. Crit Care. 2017;21:249.
Latronico N, Peli E, Calza S, Rodella F, Novelli MP, Cella A, et al. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax. 2022;77:300–3.
Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012–6.
Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry. 2008;79:838–41.
Pati S, Goodfellow JA, Iyadurai S, Hilton-Jones D. Approach to critical illness polyneuropathy and myopathy. Postgrad Med J. 2008;84:354–60.
Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann Intern Med. 2021;174:167–74.
Zorowitz RD. ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management. Chest. 2016;150:966–71.
Jones JRA, Karahalios A, Puthucheary ZA, Berry MJ, Files DC, Griffith DM, et al. Responsiveness of critically ill adults with multimorbidity to rehabilitation interventions: a patient-level meta-analysis using individual pooled data from four randomized trials. Crit Care Med. 2023. https://doi.org/10.1097/CCM.0000000000005936.
Moisey LL, Merriweather JL, Drover JW. The role of nutrition rehabilitation in the recovery of survivors of critical illness: underrecognized and underappreciated. Crit Care. 2022;26:270.
Fazzini B, Märkl T, Costas C, Blobner M, Schaller SJ, Prowle J, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27:2.
Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683–93.
Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the mini nutritional assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13:782–8.
Chapple LAS, Weinel LM, Abdelhamid YA, Summers MJ, Nguyen T, Kar P, et al. Observed appetite and nutrient intake three months after ICU discharge. Clin Nutr. 2019;38:1215–20.
Kitayama M, Unoki T, Sasaki A, Sakuramoto H, Uemura S, Tsujimoto T, et al. Appetite loss and associated factors at 1 year after intensive care unit elder survivors in a secondary analysis of the SMAP-HoPe study. Sci Rep. 2023;13:1079.
Wischmeyer PE. Are we creating survivors…or victims in critical care? Delivering targeted nutrition to improve outcomes. Curr Opin Crit Care. 2016;22:279–84.
van Zanten ARH, De Waele E, Wischmeyer PE. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit Care. 2019;23:368.
The authors wish to thank Vitaliy Kharchuk, ICU nurse, for his contributions to Fig. 3.
No funds, grants, or other support was received for this review.
Ethics approval and consent to participate
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: an incomplete title was published. The word ‘Critical’ was missing from the title.
About this article
Cite this article
Latronico, N., Rasulo, F.A., Eikermann, M. et al. Critical Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes. Crit Care 27, 439 (2023). https://doi.org/10.1186/s13054-023-04676-3